Showing 861 - 880 results of 132,575 for search '(( 5 ((((ppm decrease) OR (a decrease))) OR (nn decrease)) ) OR ( a d decrease ))', query time: 1.68s Refine Results
  1. 861

    Decrease of myopia progression with 0.025% atropine by Celso Marcelo da Cunha (4894324)

    Published 2018
    “…<p></p><p>Abstract Purpose: To demonstrate the efficacy of 0.025% atropine eyedrops in myopic children in Brazil for decreasing myopia progression Methods: This was a prospective study with 60 children from Hospital Geral Universitário and Oftalmocenter Santa Rosa in Cuiabá, MT, Brazil, aged between 6 to 12 years, with spherical equivalent refractive error of -1.00 to -6.00 diopters (D) and astigmatism of -1.00 D or smaller. …”
  2. 862
  3. 863
  4. 864
  5. 865
  6. 866
  7. 867
  8. 868
  9. 869
  10. 870
  11. 871
  12. 872
  13. 873
  14. 874
  15. 875

    A Peptide Mimetic of 5-Acetylneuraminic Acid-Galactose Binds with High Avidity to Siglecs and NKG2D by Laura L. Eggink (760403)

    Published 2015
    “…In addition, the peptide bound the receptor NKG2D, which contains a lectin-like domain that binds Neu5Ac(α2,3)Gal. …”
  16. 876

    Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

    Published 2012
    “…Representative FACS staining is shown including quantification (n = 4–5 mice per group). (E) Laquinimod decreases pathogenic potential of T cells. …”
  17. 877

    Cediranib therapy decreases tumor blood volume. by Christian T. Farrar (355177)

    Published 2013
    “…<p>(left) After 2–3 days of treatment, a statistically significant (p<0.01) difference in the rCBV (±SEM) was observed between cediranib and control groups with a 16.5±2.2% decrease for cediranib treated animals and a 14.1±2.3% increase for control animals. …”
  18. 878
  19. 879

    B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

    Published 2025
    “…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”
  20. 880